Mirion Technologies, Inc. (NYSE:MIR) Stock Has Consensus Price Target of $24.88 According to Analysts

Shares of Mirion Technologies, Inc. (NYSE:MIR) have been assigned an average recommendation of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $24.88.

Several equities analysts have recently issued reports on the company. Morgan Stanley lowered their price target on Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating on the stock in a research report on Monday, July 13th. Citigroup cut their price objective on Mirion Technologies from $28.00 to $24.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Jefferies Financial Group started coverage on Mirion Technologies in a research note on Thursday, September 3rd. They set a “buy” rating and a $20.00 target price for the company. B. Riley Financial reaffirmed a “buy” rating and set a $25.00 target price (down from $27.00) on shares of Mirion Technologies in a report on Thursday, October 29th. Finally, Weiss Ratings lowered Mirion Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, October 30th.

Hedge Funds Weigh In On Mirion Technologies

Several large investors have recently made changes to their positions in MIR. Versant Capital Management Inc boosted its position in shares of Mirion Technologies by 42.8% in the third quarter. Versant Capital Management Inc now owns 2,505 shares of the company’s stock worth $35,000 after buying an additional 751 shares during the period. GAMMA Investing LLC grew its holdings in shares of Mirion Technologies by 65.1% during the third quarter. GAMMA Investing LLC now owns 2,579 shares of the company’s stock valued at $36,000 after buying an additional 1,017 shares in the last quarter. Assetmark Inc. raised its position in Mirion Technologies by 8,123.8% during the first quarter. Assetmark Inc. now owns 3,454 shares of the company’s stock valued at $64,000 after buying an additional 3,412 shares during the period. Covestor Ltd raised its position in Mirion Technologies by 64.0% during the third quarter. Covestor Ltd now owns 3,701 shares of the company’s stock valued at $52,000 after buying an additional 1,444 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new stake in Mirion Technologies in the 3rd quarter worth about $73,000. Institutional investors own 78.51% of the company’s stock.

Mirion Technologies Trading Down 0.2%

Mirion Technologies stock opened at $17.93 on Monday. Mirion Technologies has a 12-month low of $14.04 and a 12-month high of $28.28. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.02 and a quick ratio of 2.49. The stock has a market capitalization of $4.47 billion, a PE ratio of 149.46 and a beta of 1.07. The firm has a 50 day simple moving average of $16.02 and a 200-day simple moving average of $18.15.

Mirion Technologies (NYSE:MIR) last released its earnings results on Tuesday, October 27th. The company reported $0.12 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.12. The firm had revenue of $277.80 million during the quarter, compared to the consensus estimate of $275.35 million. Mirion Technologies had a return on equity of 6.82% and a net margin of 2.69%. The firm’s revenue for the quarter was up 24.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.01 earnings per share. As a group, equities research analysts expect that Mirion Technologies will post 0.54 EPS for the current fiscal year.

Mirion Technologies Company Profile

Mirion Technologies develops radiation detection, measurement and monitoring solutions for customers in the medical, nuclear energy, industrial, defense and research markets. Its products and services help organizations measure radiation, protect workers and the public, and support the safe operation of nuclear facilities.

The company’s offerings include radiation-monitoring systems and instruments, personal dosimetry services, nuclear measurement and control equipment, and technologies used in medical imaging and radiation therapy.